2.40
price up icon0.42%   0.010
after-market Dopo l'orario di chiusura: 2.46 0.06 +2.50%
loading

Cytomx Therapeutics Inc Borsa (CTMX) Ultime notizie

pulisher
02:45 AM

What drives CytomX Therapeutics Inc. stock priceStrong return on assets - PrintWeekIndia

02:45 AM
pulisher
12:09 PM

CytomX (CTMX) Shares Promising Early Results for CRC Drug Candidate - Yahoo Finance

12:09 PM
pulisher
09:58 AM

What analysts say about CytomX Therapeutics Inc. stockSkyrocketing returns - PrintWeekIndia

09:58 AM
pulisher
07:54 AM

CytomX Therapeutics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional

07:54 AM
pulisher
06:22 AM

10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey

06:22 AM
pulisher
Jul 20, 2025

Is CytomX Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional

Jul 20, 2025
pulisher
Jul 16, 2025

Why CytomX Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes CytomX Therapeutics Inc. stock price move sharplyFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How CytomX Therapeutics Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

The Future of Allogene Therapeutics Inc: Analyzing ALLO - investchronicle.com

Jul 10, 2025
pulisher
Jul 10, 2025

Pliant Therapeutics Inc (PLRX) Stock: Navigating a Year of Volatility - investchronicle.com

Jul 10, 2025
pulisher
Jul 09, 2025

CTMX SEC FilingsCytomx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 09, 2025
pulisher
Jul 06, 2025

Do CytomX Therapeutics' (NASDAQ:CTMX) Earnings Warrant Your Attention? - Yahoo Finance

Jul 06, 2025
pulisher
Jul 03, 2025

CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC By Investing.com - Investing.com South Africa

Jul 03, 2025
pulisher
Jul 03, 2025

CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC - Investing.com

Jul 03, 2025
pulisher
Jun 25, 2025

Certain Pre-Funded warrants of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 26-JUN-2025. - MarketScreener

Jun 25, 2025
pulisher
Jun 17, 2025

CytomX Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView

Jun 17, 2025
pulisher
Jun 17, 2025

CytomX Therapeutics CEO Sells Shares to Meet Tax Obligations - TradingView

Jun 17, 2025
pulisher
Jun 13, 2025

CytomX Therapeutics Approves Key Amendments at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Stocks in play: Roots Corp. - The Globe and Mail

Jun 13, 2025
pulisher
Jun 11, 2025

Two Sigma Investments LP Cuts Stock Position in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

GoldMining Announces Closing of Flow-Through Financing and Commences Exploration at Yellowknife Gold Project - The Globe and Mail

Jun 09, 2025
pulisher
Jun 05, 2025

Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Grows Stock Holdings in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

CytomX Therapeutics jumps 54% after Q1 beat, prices $100M offering - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Earnings call transcript: CytomX Therapeutics Q4 2024 reports strong revenue By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
Jun 02, 2025

BMO Lowers Fees on Asset Allocation ETFs to Deliver Greater Value to Investors - The Globe and Mail

Jun 02, 2025
pulisher
May 31, 2025

Millennium Management LLC Grows Stake in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

May 31, 2025
pulisher
May 31, 2025

CytomX stock soars to 52-week high, hits $2.66 By Investing.com - Investing.com South Africa

May 31, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):